{"product_id":"at-the-limits-multiple-sclerosis-2023","title":"At the Limits Multiple Sclerosis 2023","description":"Multiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003e+ Include: 13 videos + 1 pdf, size: 5.61 GB\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003e+ Sample video: \u003ca href=\"https:\/\/medicalamboss.com\/contact-us\/\"\u003econtact me\u003c\/a\u003e for sample video\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"col-md-12 text-center\"\u003e\n\u003ch3\u003eThe Royal College of Physicians, London\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"col-md-12 text-center\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"col-md-12 text-center\"\u003e\u003cstrong\u003eTuesday, 26 \u0026amp; Wednesday, 27 September 2023\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-md-6 col-sm-6 column col-xs-12\"\u003e\n\u003cdiv class=\"ipBlock\" data-blockname=\"container-60013628-0-0\" data-languageid=\"0\" data-revisionid=\"1823096\" id=\"ipBlock-container-60013628-0-0\"\u003e\n\u003cdiv class=\"ipWidget ipWidget-CKEditor ipSkin-default\"\u003e\n\u003cdiv\u003e\n\u003ch2\u003eAbout the event\u003c\/h2\u003e\n\u003cbr\u003eThe 6\u003csup\u003eth\u003c\/sup\u003e Annual MS  conference is a two-day medical education meeting which brings together a notable faculty of globally acknowledged MS experts who will consider new discoveries and therapies at the limits of MS treatments.\u003cbr\u003e\u003ch4\u003eAudience: Multiple Sclerosis Specialists, Neurologists, Rehabilitation Specialists, Immunologists, Neurophysiologists, Scientists, Researchers.\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-md-6 col-sm-6 column col-xs-12\"\u003e\n\u003cdiv class=\"ipBlock\" data-blockname=\"container-60013628-0-1\" data-languageid=\"0\" data-revisionid=\"1823096\" id=\"ipBlock-container-60013628-0-1\"\u003e\n\u003cdiv class=\"ipWidget ipWidget-CKEditor ipSkin-default\"\u003e\n\u003cdiv\u003e\n\u003ch2\u003eFunders\u003c\/h2\u003e\n\u003cbr\u003eMultiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMultiple Sclerosisÿat the Limits.pdf\u003c\/li\u003e\n\u003cli\u003eAssociate Professor M Isabel Leite – Long-term treatment of NMOSD – what do we need to know to make meaningful decisions-.mp4\u003c\/li\u003e\n\u003cli\u003eDebate – DMT’s for all at diagnosis.mp4\u003c\/li\u003e\n\u003cli\u003eDirk Smeets – Demystifying AI and embedding it into clinical practice.mp4\u003c\/li\u003e\n\u003cli\u003eDr Arman Eshaghi – Redefining disease phenotyping in MS – basic science.mp4\u003c\/li\u003e\n\u003cli\u003ePanel discussion – Emerging therapies in MS.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Alberto Ascherio – EBV in MS – still in focus, or soon forgotten (again)-.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Anat Achiron – DMT in newly diagnosed people with MS – coaching or coaxing.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor David Baker – Beyond B-Cells – selective targeting of B-cell subpopulations.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Francisco J. Quintana – Cell-Cell signalling pathways- microglia and activated astrocytes.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Gavin Giovannoni – Redefining disease cell-typing in MS – clinical.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Jacqueline Palace – Long-term treatment of MOG AD – what do we need to know to make meaningful decisions.mp4\u003c\/li\u003e\n\u003cli\u003eProfessor Magd Zakaria – Treating MS Globally – the challenge of equity in MS care.mp4\u003c\/li\u003e\n\u003cli\u003eUniv. Prof. Dr. Med. Heinz Wiendl – Immunopathogenic Mechanisms.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954373693538,"sku":"MED-AMB02112","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/At-the-Limits-Multiple-Sclerosis-2023.jpg?v=1779374841","url":"https:\/\/meducourse.com\/products\/at-the-limits-multiple-sclerosis-2023","provider":"Meducourse","version":"1.0","type":"link"}